一名患有全身型幼年特发性关节炎的儿童发生心脏压塞：使用阿那白滞素阻断白细胞介素-1后病情显著改善。 - Suppr

Suppr

超能文献

Cardiac tamponade in a child with systemic-onset juvenile idiopathic arthritis: dramatic improvement after interleukin-1 blockade by anakinra.

作者信息

Merlin E, Berthomieu L, Dauphin C, Stéphan J L

出版信息

Pediatr Cardiol. 2011 Aug;32(6):862-3. doi: 10.1007/s00246-011-0009-6.

DOI:10.1007/s00246-011-0009-6

PMID:21544583

Abstract

摘要

相似文献

Cardiac tamponade in a child with systemic-onset juvenile idiopathic arthritis: dramatic improvement after interleukin-1 blockade by anakinra.一名患有全身型幼年特发性关节炎的儿童发生心脏压塞：使用阿那白滞素阻断白细胞介素-1后病情显著改善。

Pediatr Cardiol. 2011 Aug;32(6):862-3. doi: 10.1007/s00246-011-0009-6.

Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?综述：治疗全身型幼年特发性关节炎是否存在治疗时机窗？

Arthritis Rheumatol. 2014 Jun;66(6):1405-13. doi: 10.1002/art.38615.

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).一项多中心、随机、双盲、安慰剂对照的临床试验，评估白细胞介素-1 受体拮抗剂阿那白滞素治疗全身型幼年特发性关节炎（ANAJIS 试验）。

Ann Rheum Dis. 2011 May;70(5):747-54. doi: 10.1136/ard.2010.134254. Epub 2010 Dec 20.

[Anakinra treatment in refractory systemic onset juvenile arthritis].阿那白滞素治疗难治性全身型幼年特发性关节炎

An Pediatr (Barc). 2008 Mar;68(3):305-6. doi: 10.1157/13116717.

Anakinra for myocarditis in juvenile idiopathic arthritis.阿那白滞素用于幼年特发性关节炎中的心肌炎

Tex Heart Inst J. 2013;40(5):623-5.

Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report.全身性幼年特发性关节炎伴极重度血小板增多症。病例报告。

Ital J Pediatr. 2019 Jun 24;45(1):73. doi: 10.1186/s13052-019-0664-4.

Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA).阿那白滞素：全身型幼年特发性关节炎（SoJIA）的一种安全有效的一线治疗药物。

Rheumatol Int. 2012 Nov;32(11):3525-30. doi: 10.1007/s00296-011-2249-4. Epub 2011 Nov 15.

Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis.阿那白滞素治疗全身型幼年特发性关节炎的疗效预测因素。

J Rheumatol. 2019 Apr;46(4):416-421. doi: 10.3899/jrheum.180331. Epub 2019 Jan 15.

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis.对抗白细胞介素-1治疗的反应模式区分了全身型幼年特发性关节炎患者的两个亚组。

Arthritis Rheum. 2008 May;58(5):1505-15. doi: 10.1002/art.23437.

Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis.白细胞介素 1 受体拮抗剂基因多态性对全身型幼年特发性关节炎患者白细胞介素 1 阻断治疗反应的影响

Arthritis Rheumatol. 2020 Mar;72(3):499-505. doi: 10.1002/art.41130. Epub 2020 Jan 28.

引用本文的文献

Anakinra for myocarditis in juvenile idiopathic arthritis.阿那白滞素用于幼年特发性关节炎中的心肌炎

Tex Heart Inst J. 2013;40(5):623-5.

2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.2011年美国风湿病学会关于幼年特发性关节炎治疗建议的2013年更新：针对全身型幼年特发性关节炎患儿的药物治疗建议以及接受生物制剂治疗儿童的结核病筛查。

Arthritis Rheum. 2013 Oct;65(10):2499-512. doi: 10.1002/art.38092.

2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.2013 年更新的 2011 年美国风湿病学会治疗幼年特发性关节炎的建议：全身型幼年特发性关节炎儿童的药物治疗建议和接受生物制剂治疗儿童的结核筛查。

Arthritis Care Res (Hoboken). 2013 Oct;65(10):1551-63. doi: 10.1002/acr.22087.

Congenic mice provide evidence for a genetic locus that modulates spontaneous arthritis caused by deficiency of IL-1RA.同源小鼠为调节由 IL-1RA 缺乏引起的自发性关节炎的遗传基因座提供了证据。

PLoS One. 2013 Jun 28;8(6):e68158. doi: 10.1371/journal.pone.0068158. Print 2013.

本文引用的文献

Cardiac tamponade in Still disease: a review of the literature.斯蒂尔病中的心脏压塞：文献综述

South Med J. 2009 Aug;102(8):832-7. doi: 10.1097/SMJ.0b013e3181ad4847.

Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?白细胞介素-1β受体拮抗剂（阿那白滞素）成功治疗儿童特发性复发性心包炎：一种未被认识的自身炎症性疾病？

Arthritis Rheum. 2009 Jan;60(1):264-8. doi: 10.1002/art.24174.

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.托珠单抗治疗全身型幼年特发性关节炎患者的疗效和安全性：一项随机、双盲、安慰剂对照、撤药期III期试验

Lancet. 2008 Mar 22;371(9617):998-1006. doi: 10.1016/S0140-6736(08)60454-7.

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.白细胞介素-1受体拮抗剂（阿那白滞素）治疗全身型幼年特发性关节炎或成人斯蒂尔病患者：法国的初步经验。

Ann Rheum Dis. 2008 Mar;67(3):302-8. doi: 10.1136/ard.2007.076034. Epub 2007 Oct 18.

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.白细胞介素-1（IL-1）在全身型幼年特发性关节炎发病机制中的作用及对IL-1阻断的临床反应。

J Exp Med. 2005 May 2;201(9):1479-86. doi: 10.1084/jem.20050473. Epub 2005 Apr 25.

Cardiac involvement in juvenile rheumatoid arthritis.青少年类风湿关节炎的心脏受累情况。

J Pediatr. 1974 Sep;85(3):313-7. doi: 10.1016/s0022-3476(74)80107-1.

Cardiac tamponade in juvenile chronic arthritis: report of two cases and review of publications.

Ann Rheum Dis. 1990 Jul;49(7):549-53. doi: 10.1136/ard.49.7.549.

Symptomatic cardiac involvement in juvenile rheumatoid arthritis.青少年类风湿关节炎的症状性心脏受累

Int J Cardiol. 1992 Jan;34(1):57-62. doi: 10.1016/0167-5273(92)90082-e.

Juvenile rheumatoid arthritis with cardiac tamponade.青少年类风湿关节炎伴心脏压塞

Ann Rheum Dis. 1978 Jun;37(3):273-6. doi: 10.1136/ard.37.3.273.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验